Global Corporate Affairs Archives | Page 21 of 1096 | Be Korea-savvy

Archive by category Global Corporate Affairs

Private Healthcare Costs Are Rewriting the Map for Migrating Millionaires, New Data Shows

Private Healthcare Costs Are Rewriting the Map for Migrating Millionaires, New Data Shows

LONDON, Dec. 08, 2025 (Korea Bizwire) – A sharp acceleration in global wealth migration in 2025 is colliding with rapidly diverging private healthcare costs worldwide, making the availability and costs of reliable private care a decisive factor in where high-net-worth families choose to live, invest, and secure residence or citizenship rights. New client data released [...]

SHELL PLC THIRD QUARTER 2025 EURO AND GBP EQUIVALENT DIVIDEND PAYMENTS

SHELL PLC THIRD QUARTER 2025 EURO AND GBP EQUIVALENT DIVIDEND PAYMENTS

  December 8, 2025 The Board of Shell plc today announced the pounds sterling and euro equivalent dividend payments in respect of the third quarter 2025 interim dividend, which was announced on October 30, 2025 at US$0.358 per ordinary share. Shareholders have been able to elect to receive their dividends in US dollars, euros or [...]

NOTICE TO DISREGARD — ICARO Media Group

NOTICE TO DISREGARD — ICARO Media Group

NEW YORK, Dec. 08, 2025 (Korea Bizwire) – We are advised by ICARO that certain information is subject to confidentiality agreements. Journalists and other readers should disregard the news release, “ICARO Media Group Enters New Multiyear Digital Network Deal with Elevator Giant Otis in Spain, Portugal and Africa,” issued November 25, 2025 10:27 ET, over GlobeNewswire. [...]

Digital Realty Announces Access to Oracle Cloud Infrastructure in Singapore via FastConnect

Digital Realty Announces Access to Oracle Cloud Infrastructure in Singapore via FastConnect

SINGAPORE, Dec. 07, 2025 (Korea Bizwire) – Digital Realty (NYSE: DLR), the largest global provider of cloud- and carrier-neutral data center, colocation, and interconnection solutions and an Oracle Partner, today announced it will offer connectivity to an Oracle Cloud Infrastructure (OCI) FastConnect point-of-presence (PoP) within the Oracle Cloud Singapore West Region. In addition to the new connectivity, [...]

Miltenyi Biomedicine presents primary analysis of the pivotal DALY 2-EU trial for second-line relapsed/refractory large B-cell lymphoma at the 67th American Society of Hematology (ASH) Annual Meeting

Miltenyi Biomedicine presents primary analysis of the pivotal DALY 2-EU trial for second-line relapsed/refractory large B-cell lymphoma at the 67th American Society of Hematology (ASH) Annual Meeting

DALY 2-EU results show zamtocabtagene autoleucel (zamto-cel) demonstrated clinically meaningful superiority over chemoimmunotherapy in patients with relapsed/refractory large B-cell lymphoma (r/r LBCL)1 Zamto-cel was well-tolerated in the majority of patients. DALY 2-EU included a high-risk study population, characterized by older age and clinically high-risk disease features A 12-day manufacturing time resulted in a vein-to-vein time [...]

CAPHRA Raises Alarm over Legitimacy of WHO Tobacco Treaty

CAPHRA Raises Alarm over Legitimacy of WHO Tobacco Treaty

MANILA, Philippines, Dec. 08, 2025 (Korea Bizwire) – A damning analysis from the Coalition of Asia Pacific Tobacco Harm Reduction Advocates (CAPHRA), entitled “The FCTC Secretariat’s Deepening Legitimacy Problem”, exposes how the World Health Organization’s Framework Convention on Tobacco Control has been captured by American philanthropist-funded NGOs, fundamentally undermining the treaty’s credibility and harming global public health [...]

Io Therapeutics presents today at the American Society for Hematology Annual Meeting, preclinical studies demonstrating combination treatment with BCMA CAR-T cells plus the company’s RXR agonist compound IRX4204 has synergistic efficacy against human multiple myeloma

Io Therapeutics presents today at the American Society for Hematology Annual Meeting, preclinical studies demonstrating combination treatment with BCMA CAR-T cells plus the company’s RXR agonist compound IRX4204 has synergistic efficacy against human multiple myeloma

SPRING, Texas, Dec. 06, 2025 (Korea Bizwire) – Io Therapeutics, Inc., a privately held pharmaceutical company headquartered in Spring, Texas; announced today collaborative presentations at the 67th American Society of Hematology Annual Meeting and Exposition, in Orlando, Florida; with scientists from the Duke University School of Medicine in Durham, North Carolina; reporting data from preclinical studies [...]

Toripalimab Presents Long-Term Survival Benefits as 1st-line Treatment for Advanced Nasopharyngeal Carcinoma and Esophageal Squamous Cell Carcinoma Patients

Toripalimab Presents Long-Term Survival Benefits as 1st-line Treatment for Advanced Nasopharyngeal Carcinoma and Esophageal Squamous Cell Carcinoma Patients

Long-term OS follow-up analysis of JUPITER-02 demonstrates significantly better and clinically meaningful improvement with toripalimab plus chemotherapy as 1st-line treatment for R/M NPC, achieving mOS of 64.8 months and a 5-year OS rate of 52.3%. Torpalimab plus chemotherapy has been approved in over 40 countries, representing the new standard of care for the 1st line treatment [...]

Junshi Biosciences Announces Acceptance of the NDA for Roconkibart (IL-17A) for the Treatment of Moderate to Severe Plaque Psoriasis

Junshi Biosciences Announces Acceptance of the NDA for Roconkibart (IL-17A) for the Treatment of Moderate to Severe Plaque Psoriasis

SHANGHAI, Dec. 05, 2025 (Korea Bizwire) – Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the new drug application (“NDA”) for the company’s product, roconkibart injection (a recombinant humanized anti-IL-17A monoclonal antibody injection, product code: [...]

Yachting: Monaco, 7th ‘Superyacht Chef Competition’ opens for entries

Yachting: Monaco, 7th ‘Superyacht Chef Competition’ opens for entries

MONACO, Dec. 05, 2025 (Korea Bizwire) – Preparations are underway at the Yacht Club de Monaco, which has opened applications for the 7th ‘Superyacht Chef Competition’, organised with Bluewater and scheduled for 2 April 2026. The initiative, led by La Belle Classe Academy, places the spotlight on chefs who shape the onboard experience on superyachts, [...]